XNYS · Healthcare · Medical Devices
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Q1 2026 | 0.11 | 0.08 | -27.27% | $116.3M | ❌ Miss | -13.18% | -35.26% | — |
| 2026-02-12 | Q4 2025 | 0.16 | 0.17 | +6.25% | $116.0M | ✅ Beat | -1.84% | -6.52% | -10.48% |
| 2025-11-06 |
| Q3 2025 |
| 0.15 |
| 0.16 |
| +6.67% |
| $113.4M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-02-24 | Q4 2024 | 0.04 | 0.00 | -100.00% | $97.3M | ❌ Miss | -8.22% | -9.77% | -11.27% |
| 2024-11-07 | Q3 2024 | -0.06 | 0.12 | +300.00% | $95.8M | ✅ Beat | -0.93% | -6.87% | +0.07% |
| 2024-08-08 | Q2 2024 | -0.06 | 0.07 | +216.67% | $98.0M | ✅ Beat | -1.90% | -0.36% | -3.87% |
| 2024-02-15 | Q4 2023 | -0.10 | 0.11 | +210.00% | $93.7M | ✅ Beat | +4.27% | +9.26% | +10.37% |
| 2023-11-02 | Q3 2023 | -0.06 | 0.02 | +133.33% | $87.9M | ✅ Beat | +9.88% | +3.09% | +39.77% |
Showing last 8 quarters.